Asia

JN.1 designated by WHO as separate COVID-19 variant of interest

Due to its rapid growth and potential to add to the respiratory virus burden in Northern Hemisphere countries, the World Health Organization (WHO) today designated JN.1, part of the BA.2.86 SARS-CoV-2 lineage, as its own variant of interest.

Over the past month, the proportion of JN.1 viruses has rapidly increased, rising from 3.3% in early November to 27.1% by early December. Countries reporting the highest proportions include France, the United States, Singapore, Canada, and the United Kingdom.

Problem, Solution, SitRep, or ?: 

New study meaures degree that vaccine refusal is linked to mistrust in health authorities

 

...

In a new study in JAMA Network Open, authors review 28,000 interviews on vaccine uptake and hesitancy conducted in Hong Kong and Singapore from February 2020 through January 2022 to determine what was driving vaccine refusal.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Asia
howdy folks
Page loaded in 0.693 seconds.